May Measurement Month 2021: an analysis of blood pressure screening results from Bulgaria.

Autor:	Postadzhiyan A; Department of Cardiology, Medical University, Saint Anna University Hospital, 1, D. Mollov str, Sofia 1784, Bulgaria., Yotov Y; Department of Cardiology, Medical University, Varna, Bulgaria., Tisheva-Gospodinova S; Department of Cardiology, Medical University, Pleven, Bulgaria., Nikolov F; Department of Cardiology, Medical University, Plovdiv, Bulgaria., Ramchev K; Department of Intensive therapy, Military Medical Academy, Sofia, Bulgaria., Raev D; Department of Cardiology, Medical University, Saint Anna University Hospital, 1, D. Mollov str, Sofia 1784, Bulgaria., Kiru G; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK., Beaney T; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.; Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK., Janssen-Telders C; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.; Department of Cardiology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelenlaan 1117, Amsterdam, The Netherlands., Poulter NR; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Jazyk:	angličtina
Zdroj:	European heart journal supplements : journal of the European Society of Cardiology [Eur Heart J Suppl] 2024 Jul 24; Vol. 26 (Suppl 3), pp. iii20-iii22. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).
DOI:	10.1093/eurheartjsupp/suae040
Abstrakt:	Cardiovascular disease is not only the leading cause of mortality in Bulgaria, but the associated mortality rate is twice the European Union average, so screening programmes that identify subjects with elevated blood pressure (BP) are of utmost importance. May Measurement Month (MMM) is an annual global initiative that began in 2017 that aims to raise awareness of high BP. Bulgaria first joined the third campaign of MMM in 2019, and an overview of the results of Bulgarian participation in MMM21 is presented in this paper. Hypertension was defined as receiving BP-lowering medications or having a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg. Statistical analysis followed the standard MMM protocol. In Bulgaria, 155 screening sites were set up in primary and secondary care facilities, in pharmacies, and outdoor spaces across 16 administrative districts. Out of 3908 individuals screened, 2896 participants (74.1%) had hypertension. Of 2896 participants with hypertension, 76.4% were on treatment of whom 48.5% had controlled BP (<140/90 mmHg). Out of 1696 participants not on antihypertensive medication, 684 (40.3%) had elevated BP. Men were found to have higher rates of undiagnosed hypertension and lower rates of control than women. By identifying almost two-thirds of the whole screened cohort with the possibility of newly diagnosed or uncontrolled hypertension, our results confirm the importance of BP screening. Competing Interests: Conflict of interest: none declared. (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu